Trial Results Using News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Trial Results Using. Real-time updates on events, politics, business and more.

I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023

May 25, 2023

- Uliledlimab is a differentiated monoclonal antibody designed to target CD73 and promote stronger activation of patients immune system against cancer cells....

United States Hong Kong Qing Zhou Long Wu San Diego Andrew Zhu

Source: prnewswire.com

I-Mab Announces Poster Presentation of Proprietary CD73 Antibody Uliledlimab at ASCO 2023

April 26, 2023

/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...

United States Qing Zhou Hong Kong San Diego Mccormick Place Gigi Feng

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Trial Results Using News Today

I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023

I-Mab Announces Poster Presentation of Proprietary CD73 Antibody Uliledlimab at ASCO 2023

Explore More Categories